Product
SB11
Aliases
Ranibizumab, SB11 PFS
1 clinical trial
3 indications
Indication
Age-Related Macular DegenerationIndication
Macular EdemaIndication
Retinal Vein OcclusionClinical trial
An Open-label, Single Group, Single-dose Clinical Study to Evaluate the Usability of the Pre-filled Syringe of SB11 in Subjects With Neovascular Age-Related Macular Degeneration or Macular Oedema Secondary to Retinal Vein OcclusionStatus: Completed, Estimated PCD: 2023-11-30